Your browser doesn't support javascript.
loading
Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden.
Svanström, Henrik; Ueda, Peter; Melbye, Mads; Eliasson, Björn; Svensson, Ann-Marie; Franzén, Stefan; Gudbjörnsdottir, Soffia; Hveem, Kristian; Jonasson, Christian; Pasternak, Björn.
Afiliação
  • Svanström H; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  • Ueda P; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
  • Melbye M; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  • Eliasson B; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden.
  • Svensson AM; The Swedish National Diabetes Register, Västra Götalandsregionen, Gothenburg, Sweden.
  • Franzén S; The Swedish National Diabetes Register, Västra Götalandsregionen, Gothenburg, Sweden.
  • Gudbjörnsdottir S; Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Gothenburg, Sweden; The Swedish National Diabetes Register, Västra Götalandsregionen, Gothenburg, Sweden.
  • Hveem K; KG Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Faculty of Medicine and Health Science, NTNU-Norwegian University of Science and Technology, Trondheim, Norway; HUNT Research Center, Faculty of Medicine, NTNU-Norwegian University of Science and Technology, Levanger
  • Jonasson C; KG Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Faculty of Medicine and Health Science, NTNU-Norwegian University of Science and Technology, Trondheim, Norway; HUNT Research Center, Faculty of Medicine, NTNU-Norwegian University of Science and Technology, Levanger
  • Pasternak B; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark. Electronic address: bjorn.pasternak@ki.se.
Lancet Diabetes Endocrinol ; 7(2): 106-114, 2019 02.
Article em En | MEDLINE | ID: mdl-30527909
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Acidente Vascular Cerebral / Diabetes Mellitus Tipo 2 / Liraglutida / Hipoglicemiantes / Infarto do Miocárdio Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Lancet Diabetes Endocrinol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Dinamarca País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Acidente Vascular Cerebral / Diabetes Mellitus Tipo 2 / Liraglutida / Hipoglicemiantes / Infarto do Miocárdio Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Região como assunto: Europa Idioma: En Revista: Lancet Diabetes Endocrinol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Dinamarca País de publicação: Reino Unido